- The information contained on this website is provided by Janssen Research & Development, LLC. a Johnson & Johnson Company.
- This website is for informational purposes only regarding considerations for the identification and/or management of possible adverse reactions for patients participating in a clinical study using an investigational medication called pasritamig.
- This website is intended solely for use by qualified healthcare professionals who are treating study participants who are exhibiting symptoms that may be associated with participation in the study.
- This website should not be construed as medical advice or treatment recommendations. It is not a substitute for your professional medical judgment.
- Treatment responses and side effects may vary between individuals. The information contained on this site may not be suitable for everyone as it does not account for individual health status or history.
- Medical knowledge is constantly evolving. This site may be updated periodically to reflect the latest research and regulatory recommendations.
- Janssen Research & Development, LLC makes no warranties or guarantees regarding the efficacy, safety, or outcomes of following the information contained herein.
- Janssen Research & Development, LLC makes no warranties or representations regarding the accuracy, completeness, or applicability of these references.
- Please refer to the study participant’s emergency wallet card for site and sponsor contact information.
- Pasritamig’s mechanism of action is currently under evaluation. The potential impact on clinical outcomes is unknown.
Enter your password to continue
The password for this page can be found on the patient’s Participant Wallet Card.
Privacy Policy | Cookie Policy | Terms of Use | jnj.com
©2025 Johnson & Johnson. All rights reserved.
Johnson & Johnson and its logo are registered trademarks of Janssen Research & Development